These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7041522)

  • 21. [Review of the concept of vitamin D "sufficiency and insufficiency"].
    Gómez Alonso C; Naves Díaz M; Rodríguez García M; Fernández Martín JL; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():73-7. PubMed ID: 12778859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study 1,25-dihydroxycholecalciferols and 24,25-dihydroxycholecalciferols effect on ionized calcium level in blood plasma of patients with osteoporosis].
    Khodyrev VN; Spirichev VB
    Vopr Pitan; 2005; 74(2):15-9. PubMed ID: 15921199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis.
    Gallagher JC
    Metabolism; 1990 Apr; 39(4 Suppl 1):27-9. PubMed ID: 2325568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term 1,25-dihydroxyvitamin D3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis.
    Zerwekh JE; Sakhaee K; Pak CY
    J Clin Endocrinol Metab; 1985 Mar; 60(3):615-7. PubMed ID: 3871787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,25-Dihydroxyvitamin D3 and muscle strength in the elderly: a randomized controlled trial.
    Grady D; Halloran B; Cummings S; Leveille S; Wells L; Black D; Byl N
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1111-7. PubMed ID: 1939527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is 1,25-dihydroxy-cholecalciferol harmful to renal function in patients with chronic renal failure?
    Christiansen C; Rødbro P; Christensen MS; Hartnack B
    Clin Endocrinol (Oxf); 1981 Sep; 15(3):229-36. PubMed ID: 6273027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal radiocalcium transport versus urinary calcium excretion in long-term 1,25(OH)2D3 treatment.
    Caniggia A; Nuti R; Loré F; Vattimo A
    J Nucl Med Allied Sci; 1985; 29(4):325-9. PubMed ID: 3841759
    [No Abstract]   [Full Text] [Related]  

  • 29. Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol.
    Falch JA; Odegaard OR; Finnanger AM; Matheson I
    Acta Med Scand; 1987; 221(2):199-204. PubMed ID: 3035879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcitriol treatment is not effective in postmenopausal osteoporosis.
    Ott SM; Chesnut CH
    Ann Intern Med; 1989 Feb; 110(4):267-74. PubMed ID: 2913914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Falls are associated with decreased renal function and insufficient calcitriol production by the kidney.
    Gallagher JC; Rapuri P; Smith L
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):610-3. PubMed ID: 17236758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoporosis: is 1,25-(OH)2D3 of value in treatment?
    Brautbar N
    Nephron; 1986; 44(3):161-6. PubMed ID: 3785479
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of calcitriol treatment on psoriasis in hemodialysis patient: a case report.
    Gao GW; Lin SH; Chyr SH; Lin YF; Tseng SS; Lu KC
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Mar; 55(3):263-5. PubMed ID: 7780885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with oral paricalcitol in daily clinical practice for patients with chronic kidney disease stage 3-4: a preliminary study.
    Hadjiyannakos D; Filiopoulos V; Trompouki S; Sonikian M; Karatzas I; Panagiotopoulos K; Vlassopoulos D
    Clin Kidney J; 2013 Apr; 6(2):164-8. PubMed ID: 26019845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D supplementation for prevention of mortality in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD007470. PubMed ID: 24414552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of osteoporosis with vitamin D.
    Kanis JA; McCloskey EV; de Takats D; Bernard J; Zhang DM
    Osteoporos Int; 1997; 7 Suppl 3():S140-6. PubMed ID: 9536320
    [No Abstract]   [Full Text] [Related]  

  • 37. Annual injection of vitamin D and fractures of aged bones.
    Heikinheimo RJ; Inkovaara JA; Harju EJ; Haavisto MV; Kaarela RH; Kataja JM; Kokko AM; Kolho LA; Rajala SA
    Calcif Tissue Int; 1992 Aug; 51(2):105-10. PubMed ID: 1422948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,25(OH)2D3 and renal function. A controlled clinical study in normal elderly women.
    Jensen GF; Christiansen C; Transbøl I
    Acta Med Scand; 1982; 211(1-2):51-4. PubMed ID: 7041522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
    Caniggia A; Delling G; Nuti R; Lorè F; Vattimo A
    Acta Vitaminol Enzymol; 1984; 6(2):117-28. PubMed ID: 6388277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.